Clinical trial
Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent…
NCT00250835 · New Mexico Cancer Research Alliance, Other · Terminated
Key facts
| NCT number | NCT00250835 |
|---|---|
| Title | Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer |
| Official title | A Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Patients With Newly Diagnosed Resectable Rectal Cancer |
| Lead sponsor | New Mexico Cancer Research Alliance, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Cancer |
| Intervention type | Other |
| Interventions | Chemotherapy, Celecoxib, and Radiation |
| Enrollment | 38 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2012 |
| Completion | May 1, 2015 |
| First posted | Nov 8, 2005 |
| Last update posted | Sep 1, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: